Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Surface modification and functionalization of bioconjugated quantum dots (QDs) has drawn great attention for the past few years due to their wide applications in biomedical research. In this contribution, we demonstrate the use of PEGylated phospholipid micelles to encapsulate near infrared emitting ultra-small lead sulfide (PbS) QDs for in vitro and in vivo imaging. The cytotoxicity of the micelle-encapsulated QDs formulation was evaluated using MTS assay and histological analysis studies. We have found that upon encapsulating the QDs with phospholipid micelle, the toxicity of the PbS QDs is reduced, from which we envision that the PEGylated phospholipid micelle-encapsulated PbS QDs formulation can be used as theranostics probes for some selected applications in cell imaging and small animals study.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418932PMC
http://dx.doi.org/10.7150/thno.4275DOI Listing

Publication Analysis

Top Keywords

pegylated phospholipid
12
pbs qds
12
phospholipid micelle-encapsulated
8
quantum dots
8
vitro vivo
8
qds formulation
8
qds
6
micelle-encapsulated near-infrared
4
pbs
4
near-infrared pbs
4

Similar Publications

: Previous research has demonstrated that 20 kHz probe or 37 kHz bath sonication of poloxamers comprising polypropylene glycol (PPG) and polyethylene glycol (PEG) blocks can generate degradation byproducts that are toxic to mammalian cells and organisms. Herein, an investigation of a PEGylated phospholipid micelle was undertaken to identify low-molecular-weight sonolytic degradation byproducts that could be cytotoxic. The concern here lies with the fact that sonication is a frequently employed step in drug delivery manufacturing processes, during which PEGylated phospholipids can be subjected to shear forces and other extreme oxidative and thermal conditions.

View Article and Find Full Text PDF

Breast Cancer (BC) continues to exist as the leading cause of cancer-related deaths among women globally. The burden of BC continues to rise despite extensive research efforts dedicated to its diagnosis, prevention, and management. In recent years, nanotherapeutics have shown promising advancements over conventional therapies, including better drug encapsulation, reduced toxicity, multiplied stability, and extended half-life through addressing the limitations of traditional diagnostic and treatment methods.

View Article and Find Full Text PDF

Dissociable PEGylation alleviates Kupffer cells capture of PEGylated liposomal doxorubicin.

Int J Pharm

October 2025

Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, PR China. Electronic address:

Surface modification by polyethylene glycol (PEG) is valuable to assist clinical translation of lipid-based nanomedicines but suffering "PEG dilemma" due to unavoidable interaction with anti-PEG antibodies. Considering high detection rates of pre-existing anti-PEG antibodies in clinic, it is urgent to enrich PEGylation strategies to resist anti-PEG antibodies and improve drug delivery efficiency. Herein, regulatory effects of different PEGylation strategies on in vivo performance of PEGylated liposomes and related mechanisms were explored.

View Article and Find Full Text PDF

Dipalmitoylphosphatidylcholine (DPPC) lipids were encapsulated in PEGylated liposomes with free stigmasterol (ST), stigmasterol myristate (ME), and stigmasterol oleate (OE). Their quality was assessed using TEM, zeta potential, and hydrodynamic diameter measurements. The liposomes were heated to 60 °C and 180 °C.

View Article and Find Full Text PDF

Influence of structural modifications in synthetic vectors of lipid adjuvants on mRNA vaccine delivery.

Biomater Sci

September 2025

Centre for Stem Cell Research (CSCR), a unit of BRIC-Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem, Bangalore), Christian Medical College Campus, Bagayam, Vellore, Tamil Nadu, 632002, India.

Lipid adjuvants act as a fundamental element in mRNA vaccine technology by performing as diverse functional parts: augmenting immune responses, assisting genetic payload delivery to target cells, and optimizing antigen presentation. They offer various advantages, such as particle stabilization, targeted delivery, refined endosomal escape mechanisms, and self-adjuvant characteristics that amplify immune activation. The lipid adjuvant structure is crucial for both maximizing delivery accuracy and unlocking tunable immune responses, positioning lipid adjuvants as critical components of next-generation vaccines.

View Article and Find Full Text PDF